Oncotherapy Solutions LLC

Bothell, WA Molecular And Cell Biology

UEI
SBJCRLLF26A8
CAGE
6JCY9
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
  • Other Than One of the Proceeding
  • Minority Owned Business
Entity structure
Partnership or Limited Liability Partnership
SAM.gov registration date
Physical address
21430 6th Ave W, Bothell, WA 98021, USA
Website
oncotherapysolutions.com
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Novel peptide drug conjugates for the treatment of triple-negative breast cancers: direct anti-tumor activity and… R43CA221464 National Cancer Institute (NIH) $300,000

Quick answers

Is Oncotherapy Solutions LLC registered in SAM.gov?

Yes. Oncotherapy Solutions LLC's SAM.gov registration is active through September 25, 2027.

What is Oncotherapy Solutions LLC's most recent federal award?

Oncotherapy Solutions LLC's most recent federal grant award is Novel peptide drug conjugates for the treatment of triple-negative breast cancers: direct anti-tumor activity and… (R43CA221464), from National Cancer Institute (NIH), on June 1, 2018.

On GovTribe

See Oncotherapy Solutions LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login